Thanks Daltsthis last line pretty much does put things in...

First 2203 Last

Share
Profile

Follow
Dave Down Under

237 Posts.

98

26/06/23

14:18

Post #: 68472528
Share

Originally posted by dalts66: ↑

Wilkie’s powerplay – Antisense, which attracts CSL staff
Wilkie said he caught up with management of biotech Antisense Therapeutics (ASX:ANP) and the company now had a strong line-up of former staff from CSL.

“It’s essentially a new company and loaded with ex-CSL staff now including the board and many of the clinical team,” he said.

“It’s always good to see these movements after having a look under the hood – gives you a little extra confidence.”

He said he is also impressed that former Kazia Therapeutics (ASX:KZA) CEO Dr James Garner has come on as CEO and MD of ANP.

The biotech recently announced recruitment had commenced in its multicentre double-blind, placebo-controlled Phase IIb trial of lead asset ATL1102 in non-ambulant boys with Duchenne muscular dystrophy (DMD).

ANP said the first participant had been randomised and dosed with ATL1102 or Placebo in Turkey.

“We’ve always liked the asset for DMD and they recently dosed the first of 45 boys in the Phase IIb trial so we’ll have newsflow on enrolment coming through as well as some combination study results,” Wilkie said.

The Phase IIb readout is due in mid 2024.

“Yes this one is potentially binary but the upside is multiples from here on success – which we will know in the next 12 to 18 months.

“I like to think of this one as the next Neuren (ASX:NEU).”

Morgans currently have a 12-month price target of 26 cents on ANP with a speculative buy rating. The share price has dropped 40% YTD.

“It’s gone backwards in terms of share price but I don’t think the market has met the team in full yet,” Wilkie said.

“It’s hard to convince CSL scientists to jump ship to a $50m micro-cap,” he said.

Expand

Thanks Dalts

this last line pretty much does put things in crystal clear perspective..... why would anyone on their salary at CSL risk giving their income up over the next 1 to 2 yrs with cost of living as it is going unless they had a very good feel or intuition about where ANP is headed...

If I had spare cash I would buy more on 30th

“It’s hard to convince CSL scientists to jump ship to a $50m micro-cap,” he said.

ANP Price at posting: 5.8¢ Sentiment: Hold Disclosure: Held
15 Upvote

2 Great analysis

Reply

Top Stories

MM8

Medallion Metals kicking off 15,000m drill run at Ravensthorpe gold play

VUL

Vulcan appoints investment bank and M&A veteran to board

NAM

Olam Agri raises Namoi takeover offer to 75 cents a share and receives shareholder backing

Dale Gillham's weekly wrap: US fracking support boosts outlook for Australian gas stocks

ASN

Utah authorities sign off on Anson's lithium extraction plans at Green River

There are more pages in this discussion • 1,325 more messages in this thread...

First 2203 Last

Add PER (ASX) to my watchlist

(20min delay)
Last 9.0¢		Change 0.004(4.65%)		Mkt cap ! $79.33M

Open	High	Low	Value	Volume
8.6¢	9.0¢	8.5¢	$152.9K	1.730M

Buyers (Bids)

No.	Vol.	Price($)
2	71023	8.9¢

Sellers (Offers)

Price($)	Vol.	No.
9.1¢	204072	3

View Market Depth

No.	Vol.	Price($)
2	71023	0.089
1	99721	0.088
1	115000	0.087
1	50000	0.086
2	183179	0.085

Price($)	Vol.	No.
0.091	204072	3
0.092	50000	1
0.093	50000	1
0.094	160000	1
0.095	550000	2

Last trade - 14.19pm 13/09/2024 (20 minute delay)

PER (ASX) Chart

Thanks Daltsthis last line pretty much does put things in...

Medallion Metals kicking off 15,000m drill run at Ravensthorpe gold play

Vulcan appoints investment bank and M&A veteran to board

Olam Agri raises Namoi takeover offer to 75 cents a share and receives shareholder backing

Dale Gillham's weekly wrap: US fracking support boosts outlook for Australian gas stocks

Utah authorities sign off on Anson's lithium extraction plans at Green River

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Thanks Daltsthis last line pretty much does put things in...

Top Stories

Medallion Metals kicking off 15,000m drill run at Ravensthorpe gold play

Vulcan appoints investment bank and M&A veteran to board

Olam Agri raises Namoi takeover offer to 75 cents a share and receives shareholder backing

Dale Gillham's weekly wrap: US fracking support boosts outlook for Australian gas stocks

Utah authorities sign off on Anson's lithium extraction plans at Green River

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News